Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Feb 6, 2020, after the close
10-K filed Feb 28, 2020, 59 days after period end · 0001299130-20-000008
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | $27.93M | $19.53M | $24.94M | $25.72M |
| Net Income | -$91.00K | -$30.80M | -$20.76M | -$19.03M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
